Related references
Note: Only part of the references are listed.Improving the Prediction of Local Drug Distribution Profiles in the Brain with a New 2D Mathematical Model
E. Vendel et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2019)
Protein-ligand pose and affinity prediction: Lessons from D3R Grand Challenge 3
Panagiotis I. Koukos et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
NHS prescribed record number of antidepressants last year
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2019)
Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
Joan Forns et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Insights on the Multifunctional Activities of Magnolol
Jianhong Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Computational methods and tools to predict cytochrome P450 metabolism for drug discovery
Jonathan D. Tyzack et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Integrating mental health into primary care for addressing depression in a rural population: An experience from North India
M. A. Bashar et al.
INDIAN JOURNAL OF PSYCHIATRY (2019)
Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants
Laura M. Kemppainen et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2018)
Protein structure-based drug design: from docking to molecular dynamics
Pawel Sledz et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Safety and Toxicology of Magnolol and Honokiol
Andrea Sarrica et al.
PLANTA MEDICA (2018)
Current Strategies for Brain Drug Delivery
Xiaowei Dong
THERANOSTICS (2018)
Out-compute drug side effects: Focus on cytochrome P450 2D6 modeling
Charleen G. Don et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2018)
Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective
Quanguo He et al.
CELLS (2018)
Kinetic mechanism of time-dependent inhibition of CYP2D6 by 3,4-methylenedioxymethamphetamine (MDMA): Functional heterogeneity of the enzyme and the reversibility of its inactivation
John T. Rodgers et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors
Zbigniew Dutkiewicz et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2018)
Difference in Mechanism-Based Inhibition of Cytochrome P450 3A4 and 3A5 by a Series of Fluoroquinolone Antibacterial Agents
Akiko Watanabe et al.
DRUG METABOLISM AND DISPOSITION (2017)
Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations
Zoe Cournia et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Complementary Therapies for Mental Health Disorders
Gary N. Asher et al.
MEDICAL CLINICS OF NORTH AMERICA (2017)
A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature
Johannes Hochleitner et al.
SCIENTIFIC REPORTS (2017)
Biodegradation of Cosmetics Products: A Computational Study of Cytochrome P450 Metabolism of Phthalates
Fabian G. Cantu Reinhard et al.
INORGANICS (2017)
Curcumin, Piperine, and Capsaicin: A Comparative Study of Spice-Mediated Inhibition of Human Cytochrome P450 Isozyme Activities
Suhaili Shamsi et al.
DRUG METABOLISM AND DISPOSITION (2017)
Phyto-anesthetics: A mini-review on herb-anesthesia drug interactions
Sepideh Vahabi et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Andre F. Carvalho et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2016)
Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6
Virginie Y. Martiny et al.
BIOINFORMATICS (2015)
Regulation of neuronal communication by G protein-coupled receptors
Yunhong Huang et al.
FEBS LETTERS (2015)
Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding
An Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Molecular Docking and Structure-Based Drug Design Strategies
Leonardo G. Ferreira et al.
MOLECULES (2015)
Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6*1 and CYP2D6*10 using cell-based models in vitro
Qiang Qu et al.
ACTA PHARMACOLOGICA SINICA (2014)
Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Lucy Sanchez-Covarrubias et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
V. Abbing-Karahagopian et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
Martins Ekor
FRONTIERS IN PHARMACOLOGY (2014)
Use of Complementary and Alternative Medical Therapies Among Youth With Mental Health Concerns
Kathi J. Kemper et al.
ACADEMIC PEDIATRICS (2013)
Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise
David Ryan Koes et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Effect of Honokiol on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
Hyeon-Uk Jeong et al.
MOLECULES (2013)
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
Arup K. Ghose et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Clinical Evidence of Herbal Drugs As Perpetrators of Pharmacokinetic Drug Interactions
Robert Hermann et al.
PLANTA MEDICA (2012)
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Satoshi Yamaori et al.
DRUG METABOLISM AND DISPOSITION (2011)
Understanding the determinants of selectivity in drug metabolism through modeling of dextromethorphan oxidation by cytochrome P450
Julianna Olah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4
Jinghu Li et al.
XENOBIOTICA (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme
Bo Wang et al.
DRUG METABOLISM REVIEWS (2009)
Mechanism-based inactivation of human cytochromes P450s: Experimental characterization, reactive intermediates, and clinical implications
Paul F. Hollenberg et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)
Kanako Sakuyama et al.
DRUG METABOLISM AND DISPOSITION (2008)
Ion channels as drug targets: The next GPCRs
Gregory J. Kaczorowski et al.
JOURNAL OF GENERAL PHYSIOLOGY (2008)
Clinical assessment of CYP2D6-mediated herb-drug interactions in humans:: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea
Bill J. Gurley et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
Leukothea Ioakimidis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol
Bent H. Hellum et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana
HJ Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum
Subehan et al.
PLANTA MEDICA (2006)
Crystal structure of human cytochrome P450 2D6
P Rowland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6
C Sridar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers
HL Liston et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Transport of glutamate and other amino acids at the blood-brain barrier
QR Smith
JOURNAL OF NUTRITION (2000)
Share Paper
